Literature DB >> 21455853

Gender and the risk of venous thromboembolism.

Daniela Tormene1, Valeria Ferri, Sara Carraro, Paolo Simioni.   

Abstract

The role of gender in the causation of first and recurrent venous thromboembolism (VTE) is uncertain. The use of hormonal therapy and pregnancy has been associated with VTE in women. Epidemiological studies have described a higher incidence of first VTE in women of childbearing age. Nevertheless, no consistent differences in the overall incidence of VTE between males and females have been found. Recent studies have shown that women exhibit a lower risk of recurrent VTE than men, although these data were not confirmed in other studies that evaluated only women with idiopathic VTE. This article reviews the role of gender as a risk factor for first and recurrent VTE. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21455853     DOI: 10.1055/s-0031-1273083

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  9 in total

Review 1.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

2.  Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia.

Authors:  Brynne Underwood; Qiuhong Zhao; Alison R Walker; Alice S Mims; Sumithira Vasu; Meixiao Long; Tamanna Z Haque; Bradley W Blaser; Nicole R Grieselhuber; Sarah A Wall; Gregory K Behbehani; James S Blachly; Karilyn Larkin; John C Byrd; Ramiro Garzon; Tzu-Fei Wang; Bhavana Bhatnagar
Journal:  Int J Hematol Oncol       Date:  2020-09-04

3.  Medical management of venous thromboembolism: what the interventional radiologist needs to know.

Authors:  Raj S Kasthuri; Nigel S Key
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

4.  Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis.

Authors:  Holm Eggemann; Anna-Lena Bernreiter; Mattea Reinisch; Sibylle Loibl; Florin-Andrei Taran; Serban-Dan Costa; Atanas Ignatov
Journal:  Br J Cancer       Date:  2019-01-17       Impact factor: 7.640

5.  A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia.

Authors:  Hind M Alosaimi; Saeed Alqahtani; Bander Balkhi; Mishari Alqahtani; Faisal Alzamil; Abdulaziz Alhossan; Fatmah S Alqahtany; Abdullah A Alharbi; Nawaf Abdullah Alqahtani; Hanan Albackr; Ghada Elgohary; Farjah H Algahtani
Journal:  PeerJ       Date:  2022-09-09       Impact factor: 3.061

6.  PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1.

Authors:  Juan Carlos Corona; Senio Campos de Souza; Michael R Duchen
Journal:  Exp Neurol       Date:  2013-12-26       Impact factor: 5.330

Review 7.  Recurrent venous thromboembolism: what is the risk and how to prevent it.

Authors:  Gualtiero Palareti
Journal:  Scientifica (Cairo)       Date:  2012-09-17

Review 8.  Gender differences in ocular blood flow.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  Curr Eye Res       Date:  2014-06-03       Impact factor: 2.424

9.  Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS-CAT Study.

Authors:  Sally Temraz; Nour Moukalled; Grigorios T Gerotziafas; Ismail Elalamy; Luis Jara-Palomares; Maya Charafeddine; Ali Taher
Journal:  Cancers (Basel)       Date:  2021-03-02       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.